Premature aging and cancer development in transgenic mice lacking functional CYLD

Area of Science:

• Cell Biology
• Oncology
• Aging Research

Background:

• CYLD is a deubiquitinating enzyme recognized for its tumor suppressor functions.
• Mutations in CYLD are linked to skin appendage tumors and other cancers.

Purpose of the Study:

• To investigate the role of CYLD in aging and cancer development.
• To characterize the phenotype of mice expressing a catalytically inactive CYLD mutant.

Main Methods:

• Generation of transgenic mice (K5-CYLD^C/S) expressing a mutant CYLD protein lacking deubiquitinase activity.
• Phenotypic analysis of K5-CYLD^C/S mice, including histological examination and assessment of aging indicators.
• Investigation of molecular pathways involved in premature aging and tumor development.

Main Results:

• K5-CYLD^C/S mice displayed epidermal, hair follicle, and sebaceous gland alterations.
• Transgenic mice exhibited premature aging phenotypes, including alopecia and kyphosis, by 3 months of age.
• Accelerated aging signs were observed in multiple organs, and mice developed spontaneous tumors.
• Over-activation of NF-κB, Akt, JNK, c-Myc, and chronic inflammation were identified as underlying mechanisms.

Conclusions:

• The tumor suppressor CYLD plays a critical role in preventing premature aging and cancer.
• Loss of CYLD deubiquitinase function in mice leads to accelerated aging and increased tumor susceptibility.
• Dysregulation of inflammatory and signaling pathways contributes to the CYLD-deficient aging phenotype.